OKYO Pharma Limited
EMMLF · OTC
3/31/2025 | 10/1/2024 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,027 | – | -$3 | -$8 |
| Dep. & Amort. | $1 | – | $1 | $0 |
| Deferred Tax | $0 | – | $0 | $0 |
| Stock-Based Comp. | $1 | – | $1 | $4 |
| Change in WC | $639 | – | -$0 | $0 |
| Other Non-Cash | -$183 | – | -$241 | $1 |
| Operating Cash Flow | -$1,570 | – | -$241 | -$3 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | – | $0 | $0 |
| Net Acquisitions | $0 | – | $0 | $0 |
| Inv. Purchases | $0 | – | $0 | $0 |
| Inv. Sales/Matur. | $0 | – | $0 | $0 |
| Other Inv. Act. | $0 | – | $0 | $0 |
| Investing Cash Flow | -$1 | – | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $400 | – | $550 | $0 |
| Stock Issued | $1,706 | – | $0 | $0 |
| Stock Repurch. | $0 | – | $0 | $0 |
| Dividends Paid | $0 | – | $0 | $0 |
| Other Fin. Act. | -$1 | – | $2 | $2 |
| Financing Cash Flow | $2,105 | – | $552 | $2 |
| Forex Effect | $41 | – | -$31 | -$0 |
| Net Chg. in Cash | $574 | – | $280 | -$2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $987 | – | $707 | $2 |
| End Cash | $1,561 | – | $987 | $0 |
| Free Cash Flow | -$1,572 | – | -$241 | -$3 |